Scholarly publications and presentations by Rochester Regional Health's Infectious Diseases department authors.

Follow


Submissions from 2022

Link

1-2022          Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post-discharge assessed by Respiratory Intensity and Impact Questionnaire, Ann R. Falsey, Rochester Regional Health, Edward E. Walsh, Rochester Regional Health, Richard H. Osborne, Department of Health and Medical Sciences, Swinburne University of Technology, Melbourne, Victoria, Australia., et al.

Link

1-1-2022          Cost determinants among adults hospitalized with respiratory syncytial virus in the United States, 2017–2019, Yoonyoung Choi, Merck & Co., Inc., Alexandra Hill-Ricciuti, Columbia University Irving Medical Center, Angela R. Branche, University of Rochester, et al.

Link

1-1-2022          Dynamic changes in otopathogens colonizing the nasopharynx and causing acute otitis media in children after 13-valent (PCV13) pneumococcal conjugate vaccination during 2015–2019, Ravinder Kaur, Rochester Regional Health; Naoko Fuji, Rochester Regional Health; and Michael E. Pichichero, Rochester Regional Health

Submissions from 2021

Link

12-28-2021          A systems genomics approach uncovers molecular associates of RSV severity, Matthew N. McCall, Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester New York, United States of America., Chin-Yi Chu, Division of Neonatology and Pediatric Molecular and Personalized Medicine Program, University of Rochester Medical Center, Rochester New York, United States of America., Lu Wang, Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester New York, United States of America., et al.

Link

12-16-2021          Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine, Ann R. Falsey, Rochester Regional Health, Magdalena E. Sobieszczyk, Ian Hirsch, et al.

Link

12-10-2021          A panel of diverse Pseudomonas aeruginosa clinical isolates for research and development, Francois Lebreton, Walter Reed Army Institute of Research, Erik Snesrud, Walter Reed Army Institute of Research, Mary Hinkle, Rochester Regional Health, et al.

Link

11-12-2021          Diagnosis of Streptococcus pneumoniae infection using circulating antibody secreting cells, Shuya Kyu, Emory University School of Medicine, Richard P. Ramonell, Emory University School of Medicine, Merin Kuruvilla, Emory University School of Medicine, et al.

Link

11-1-2021          Pneumonia, Sinusitis, Influenza and Other Respiratory Illnesses in Acute Otitis Media-Prone Children, Michael E. Pichichero, Rochester Regional Health; Timothy J. Chapman, Rochester Regional Health; and Peter Bajorski, Rochester Institute of Technology

Link

11-1-2021          Risk Factors and Medical Resource Utilization of Respiratory Syncytial Virus, Human Metapneumovirus, and Influenza-Related Hospitalizations in Adults-A Global Study During the 2017-2019 Epidemic Seasons (Hospitalized Acute Respiratory Tract Infection [HARTI] Study), Ann R. Falsey, Rochester Regional Health, Edward E. Walsh, Rochester Regional Health, Stacey House, Washington University School of Medicine, St Louis, Missouri, USA., et al.

Link

10-26-2021          Transition of Serotype 35B Pneumococci From Commensal to Prevalent Virulent Strain in Children, Naoko Fuji, Rochester Regional Health, Michael Pichichero, Rochester Regional Health, Rachel L. Ehrlich, Drexel University College of Medicine, et al.

File

10-21-2021          COVID Update, Maryrose Laguio-Vila, Rochester Regional Health; Emil P. Lesho, Rochester Regional Health; and Edward E. Walsh, Rochester Regional Health

Link

10-18-2021          Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial, Andre C. Kalil, University of Nebraska Medical Center, Omaha, NE, USA., Aneesh K. Mehta, Emory University, Atlanta, GA, USA., Thomas F. Patterson, University of Texas Health San Antonio, University Health System, and the South Texas Veterans Health Care System, San Antonio, TX, USA., et al.

Link

9-13-2021          COVID-19 Pandemic Impact on Respiratory Infectious Diseases in Primary Care Practice in Children, Ravinder Kaur, Rochester Regional Health, Steven Schulz, Rochester Regional Health, Naoko Fuji, Rochester Regional Health, et al.

Link

9-1-2021          Nasopharyngeal microbiome composition associated with Streptococcus pneumoniae colonization suggests a protective role of Corynebacterium in young children, Lei Xu, Rochester Regional Health; Joshua Earl, Drexel University College of Medicine; and Michael E. Pichichero, Rochester Regional Health

8-10-2021          Bad Bugs (No) Some Drugs, Anja Bottler, Rochester Regional Health

Link

7-27-2021          Haemophilus influenzae Prevalence, Proportion of Capsulated Strains and Antibiotic Susceptibility During Colonization and Acute Otitis Media in Children, 2019-2020, Naoko Fuji, Rochester Regional Health; Michael Pichichero, Rochester Regional Health; and Ravinder Kaur, Rochester Regional Health

File

7-15-2021          COVID 19 Vaccine Update: So Many New Questions What's Next?, Edward E. Walsh, Rochester Regional Health

Link

6-29-2021          Urinary Tract Infection Stewardship: A Urinary Antibiogram and Electronic Medical Record Alert Nudging Narrower-Spectrum Antibiotics for Urinary Tract Infections, Maryrose Laguio-Vila, Rochester Regional Health, Mary L. Staicu, Rochester Regional Health, Mary Lourdes Brundige, Rochester Regional Health, et al.

Link

6-7-2021          The Rationale for Including Osteopathic Manipulative Treatment in the Management of Infections: a Hermeneutic Review, Emil Lesho, Rochester Regional Health; Allison McKeown, University of Rochester/Highland Hospital, NY; and Maryrose Laguio-Vila, Rochester Regional Health

Link

5-20-2021          Temporal Dysbiosis of Infant Nasal Microbiota Relative to Respiratory Syncytial Virus Infection, Alex Grier, University of Rochester School of Medicine and Dentistry, Rochester, New York, Ann L. Gill, University of Rochester School of Medicine and Dentistry, Rochester, New York, Haeja A. Kessler, University of Rochester School of Medicine and Dentistry, Rochester, New York, et al.

Link

4-30-2021          Convalescent Plasma in the Management of COVID-19 Pneumonia, Ayman Elbadawi, University of Texas Medical Branch, Galveston, TX, Mina Shnoda, Allegheny General Hospital, Pittsburgh, PA, Maryrose Laguio-Vila, Rochester Regional Health, et al.

Link

4-19-2021          Animal Zoonotic Related Diseases, Mina S. Said, Rochester Regional Health; Ekta Tirthani, Rochester Regional Health; and Emil Lesho, Rochester Regional Health

Link

4-2021          Early Life RSV: Can Vaccines Help Fix Societal Ills?, Mary T. Caserta, University of Rochester School of Medicine and Edward E. Walsh, Rochester Regional Health

Link

3-2-2021          Passive Immunity Trial for Our Nation (PassITON): Study Protocol for a Randomized Placebo-Control Clinical Trial Evaluating COVID-19 Convalescent Plasma in Hospitalized Adults, Wesley H. Self, Vanderbilt University Medical Center, Thomas G. Stewart, Vanderbilt University Medical Center, Allison P. Wheeler, Vanderbilt University Medical Center, Nashville, Tennessee, et al.

Link

3-1-2021          Rising Pneumococcal Antibiotic Resistance in the Post-13-Valent Pneumococcal Conjugate Vaccine Era in Pediatric Isolates from a Primary Care Setting, Ravinder Kaur, Rochester Regional Health, Minh Pham, Rochester Institute of Technology, Karl O.A. Yu, Rochester Regional Health, et al.